Alan Colowick - 01 Apr 2025 Form 4 Insider Report for ALUMIS INC. (ALMS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Apr 2025, 18:05:40 UTC
Prior SEC filing
30 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sara Klein, Attorney-in-Fact

Key filing fact

Alan Colowick filed Form 4 for ALUMIS INC. (ALMS) on 03 Apr 2025.

Key facts

  • This page summarizes Alan Colowick's Form 4 filing for ALUMIS INC. (ALMS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Apr 2025, 18:05.

Change

  • Previous filing in this sequence was filed on 30 Jan 2025.
  • Current net transaction value: +$129,544.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALMS transaction

Common Stock

Purchase

Transaction value
$112,309
Shares
+16,104
Change %
Price
$6.97
Shares after
16,104
Date
01 Apr 2025
Ownership
By Revocable Living Trust
Footnotes
F1, F2
ALMS transaction

Common Stock

Purchase

Transaction value
$17,235
Shares
+2,300
Change %
+14%
Price
$7.49
Shares after
18,404
Date
02 Apr 2025
Ownership
By Revocable Living Trust
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $6.79 to $7.10. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

Shares are held directly by The Colowick Trust, for which Reporting Person serves as a trustee.

Footnote F3

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $7.33 to $7.75. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .